Chantal van Litsenburg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chantal van Litsenburg has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Cristina Garzon-Rodriguez
Institute of Oncology Catalá ICO-IDIBELL, Avenue Gran Via de l'Hospitalet, 199-203, Hospitalet de Llobregat, Barcelona 08908, Spain
1 shared publication - Epaminontas Samantas
Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, 14564 Athens, Greece
1 shared publication - Juan Manuel Sepúlveda-Sánchez
HM Sanchinarro University Hospital , Madrid
1 shared publication - Leonidas Lyras
Pfizer, Athens, Greece
1 shared publication - Luis Olay Gayoso
Medical Oncology Radiotherapy Unit in Huca Oviedo, Gijon y alrededores, Spain
1 shared publication - Mette Strand
Pfizer, Ballerup, Denmark
1 shared publication
Latest Publications
- Open Access
- 7 November 2013
- Published by Springer Nature in BMC Palliative Care
- Vol. 12 (1) , 41
Cancer-related neuropathic pain in out-patient oncology clinics: a European survey
Although pain is frequently experienced by patients with cancer, it remains under-treated. The primary aim of this study was to estimate the prevalence of cancer-related neuropathic pain (CRNP) in patients with chronic pain who attended an outpatient clinic for standard care in Europe (irrespective of the reason or stage of the cancer). The secondary aims of this study were to characterise pain and cancer in patients with CRNP (including treatment) and to evaluate the usefulness of the painDETECT (PD-Q) screening tool to help physicians identify a potential neuropathic component of cancer-related pain.
- 7 November 2013
- Published by Springer Nature in BMC Palliative Care
- Vol. 12 (1) , 41
Open AccessCancer-related neuropathic pain in out-patient oncology clinics: a European survey
Although pain is frequently experienced by patients with cancer, it remains under-treated. The primary aim of this study was to estimate the prevalence of cancer-related neuropathic pain (CRNP) in patients with chronic pain who attended an outpatient clinic for standard care in Europe (irrespective of the reason or stage of the cancer). The secondary aims of this study were to characterise pain and cancer in patients with CRNP (including treatment) and to evaluate the usefulness of the painDETECT (PD-Q) screening tool to help physicians identify a potential neuropathic component of cancer-related pain.